Title : Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).

Pub. Date : 2010 Jan

PMID : 19453623






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing"s disease: comparison with GH-releasing peptide-6 (GHRP-6). Ghrelin proopiomelanocortin Homo sapiens
2 BACKGROUND: In Cushing"s disease (CD), adrenocorticotrophic hormone (ACTH)/cortisol responses to growth hormone secretagogues (GHS), such as ghrelin and GHRP-6, are exaggerated. Ghrelin proopiomelanocortin Homo sapiens
3 OBJECTIVE: To compare ghrelin- and GHRP-6-induced ACTH/cortisol release before and after ketoconazole treatment in patients with CD. Ghrelin proopiomelanocortin Homo sapiens
4 An increase in basal ACTH (before: 11.2 +/- 1.6 pmol/l; 6th month: 19.4 +/- 2.7) and in ghrelin-stimulated peak ACTH values occurred after 6 months (before: 59.8 +/- 15.4; 6th month: 112.0 +/- 11.2). Ghrelin proopiomelanocortin Homo sapiens
5 The enhanced ACTH responses to ghrelin after ketoconazole in CD could also be due to activation of the hypothalamic-pituitary-adrenal axis and/or to an increase in GHS-receptors expression in the corticotroph adenoma, consequent to reductions in circulating glucocorticoids. Ghrelin proopiomelanocortin Homo sapiens